Biomea Fusion Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Biomea Fusion is a clinical-stage biotechnology company focused on developing oral small molecule therapies for diabetes and obesity, with icovamenib and BMF-650 advancing its pipeline. Its work aims to address metabolic disorders that affect a large portion of the global population, seeking to improve health outcomes for patients living with diabetes, obesity, and related conditions. Based in San Carlos, California, the company operates within the biotechnology research sector and is organized to pursue transformative treatments in metabolic disease.